Clinical trial · Interventional
Evaluation of Nutrition and Metabolism in Breast Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Recruitment challenges
Summary
Brief summary (as posted)
With the increased success in breast cancer therapies, survivors develop unhealthy changes in body composition, such as muscle loss and fat gains, which lead to increased risk of cardiovascular disease and diabetes in survivorship. This study will examine the effects of a nutrition, cardiovascular and strength exercise program compared with a yoga program (representing usual care) on body composition and metabolism in recently diagnosed breast cancer patients. Nutrition and exercise may improve various body composition and metabolic parameters, which may improve quality of life in survivorship, reduce risk of recurrence and reduce the risk of developing cardiovascular disease and diabetes in survivorship.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nutrition and Exercise Group | Behavioral | — | UNRESOLVED |
| Yoga and Stretching Group | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Yoga and Stretching Group
- description
- Patients undergo yoga and stretching exercises
- interventionNames
- Behavioral: Yoga and Stretching Group
- type
- ACTIVE_COMPARATOR
- label
- Nutrition and Exercise Group
- description
- Patients are provided with nutrition, cardiovascular exercise and strength exercise consultations
- interventionNames
- Behavioral: Nutrition and Exercise Group
Primary outcomes (1)
- measure
- Change in glucose parameters from baseline
- timeFrame
- Baseline, 8 weeks, 16 weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Females 18 years old or older * Recent diagnosis of breast cancer and up to 4 weeks following the first cycle of chemotherapy or up to the first 4 weeks of radiation therapy * Clinical Stages I-IIIa * Able to communicate freely in English * Have sufficient cognitive ability to participate and provide informed consent Exclusion Criteria: * Any known diagnosis of cardiovascular disease and thyroid disease that is not currently managed with medication or other therapies * Any known diagnosis of diabetes or HIV * Pre-existing injuries or health conditions that prevents the patient's safe participation in exercise * Any previous diagnosis of cancer within the last 5 years (other than carcinoma in situ) * Fasting glucose \>7.0 mM at baseline of the study * Pregnant individuals will be excluded from this study
References
Publications (0)
Data not yet available